Multimodality therapy for the treatment of muscle-invasive bladder cancer

S. A. Thurman, Theodore DeWeese

Research output: Contribution to journalArticle

Abstract

In the United States, local management of muscle-invasive bladder cancer largely remains radical cystectomy with urinary diversion. However, this approach is undergoing transition. Organ-preserving approaches using a combination of multiple modalities have been successfully applied to the management of several types of cancer and clearly play an important role in the management of muscle-invasive bladder cancer as well. Since the 1980s, several single and multi-institutional trials have confirmed that a combined modality organ-preserving approach (chemotherapy administered in conjunction with radiation) consistently confers equivalent overall survival compared with survival following radical cystectomy. These trials are very encouraging and allow organ preservation to be considered an appropriate therapeutic option for patients with muscle-invasive bladder cancer. Copyright (C) 2000 by W.B. Saunders Company.

Original languageEnglish (US)
Pages (from-to)313-322
Number of pages10
JournalSeminars in Urologic Oncology
Volume18
Issue number4
StatePublished - 2000

Fingerprint

Urinary Bladder Neoplasms
Cystectomy
Muscles
Organ Preservation
Urinary Diversion
Survival
Therapeutics
Radiation
Drug Therapy
Neoplasms

Keywords

  • Bladder cancer
  • Organ preservation
  • Radiation therapy

ASJC Scopus subject areas

  • Urology

Cite this

Multimodality therapy for the treatment of muscle-invasive bladder cancer. / Thurman, S. A.; DeWeese, Theodore.

In: Seminars in Urologic Oncology, Vol. 18, No. 4, 2000, p. 313-322.

Research output: Contribution to journalArticle

@article{e6b4cd614359495e91d586b8518148da,
title = "Multimodality therapy for the treatment of muscle-invasive bladder cancer",
abstract = "In the United States, local management of muscle-invasive bladder cancer largely remains radical cystectomy with urinary diversion. However, this approach is undergoing transition. Organ-preserving approaches using a combination of multiple modalities have been successfully applied to the management of several types of cancer and clearly play an important role in the management of muscle-invasive bladder cancer as well. Since the 1980s, several single and multi-institutional trials have confirmed that a combined modality organ-preserving approach (chemotherapy administered in conjunction with radiation) consistently confers equivalent overall survival compared with survival following radical cystectomy. These trials are very encouraging and allow organ preservation to be considered an appropriate therapeutic option for patients with muscle-invasive bladder cancer. Copyright (C) 2000 by W.B. Saunders Company.",
keywords = "Bladder cancer, Organ preservation, Radiation therapy",
author = "Thurman, {S. A.} and Theodore DeWeese",
year = "2000",
language = "English (US)",
volume = "18",
pages = "313--322",
journal = "Urologic Oncology",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Multimodality therapy for the treatment of muscle-invasive bladder cancer

AU - Thurman, S. A.

AU - DeWeese, Theodore

PY - 2000

Y1 - 2000

N2 - In the United States, local management of muscle-invasive bladder cancer largely remains radical cystectomy with urinary diversion. However, this approach is undergoing transition. Organ-preserving approaches using a combination of multiple modalities have been successfully applied to the management of several types of cancer and clearly play an important role in the management of muscle-invasive bladder cancer as well. Since the 1980s, several single and multi-institutional trials have confirmed that a combined modality organ-preserving approach (chemotherapy administered in conjunction with radiation) consistently confers equivalent overall survival compared with survival following radical cystectomy. These trials are very encouraging and allow organ preservation to be considered an appropriate therapeutic option for patients with muscle-invasive bladder cancer. Copyright (C) 2000 by W.B. Saunders Company.

AB - In the United States, local management of muscle-invasive bladder cancer largely remains radical cystectomy with urinary diversion. However, this approach is undergoing transition. Organ-preserving approaches using a combination of multiple modalities have been successfully applied to the management of several types of cancer and clearly play an important role in the management of muscle-invasive bladder cancer as well. Since the 1980s, several single and multi-institutional trials have confirmed that a combined modality organ-preserving approach (chemotherapy administered in conjunction with radiation) consistently confers equivalent overall survival compared with survival following radical cystectomy. These trials are very encouraging and allow organ preservation to be considered an appropriate therapeutic option for patients with muscle-invasive bladder cancer. Copyright (C) 2000 by W.B. Saunders Company.

KW - Bladder cancer

KW - Organ preservation

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=0033694919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033694919&partnerID=8YFLogxK

M3 - Article

C2 - 11101096

AN - SCOPUS:0033694919

VL - 18

SP - 313

EP - 322

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 4

ER -